Table 2.
Study Name | LOE | Prepectoral | Subpectoral | Subpectoral Plane | Follow-up Period, mo | ||
---|---|---|---|---|---|---|---|
Patients, n | Breasts, n | Patients, n | Breasts, n | ||||
Avila et al7 | III | 116 | 203 | 114 | 202 | DP | NR |
ElSherif et al8 | III | NR | 205 | NR | 366 | TSM | 20 |
Franceschini et al5 | III | 82 | 109 | 95 | 146 | TSM | 20 (PP), 16 (TSM) |
Ng et al9 | III | 40 | 50 | 40 | 59 | DP | 21 (PP), 26.5 (DP) |
Sbitany et al58 | III | 51 | 84 | 115 | 186 | DP | 11.1 (PP), 12.5 (DP) |
Braun et al10 | III | 116 | 209 | 44 | 79 | DP | 16 (PP), 24 (DP) |
LOE, level of evidence, NR, not reported.